Immune checkpoint inhibitor Clinical Trials

10 recruitingDrug
Phase 24Phase 12Phase 32Not Applicable1

Showing 110 of 10 trials

Recruiting
Phase 3

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

ETOP IBCSG Partners Foundation180 enrolled15 locationsNCT05522660
Recruiting
Phase 3

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Phase 1Phase 2

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

Advanced Solid Tumors
Domain Therapeutics Australia Pty Ltd125 enrolled8 locationsNCT06819735
Recruiting
Phase 2

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Locally Advanced Colorectal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences170 enrolled3 locationsNCT06154538
Recruiting
Phase 1Phase 2

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Unspecified Adult Solid Tumor, Protocol Specific
Maastricht University Medical Center126 enrolled5 locationsNCT04954599
Recruiting

Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

Shanghai Chest Hospital250 enrolled1 locationNCT06730503
Recruiting
Phase 2

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Non-small Cell Lung Cancer
Peking Union Medical College Hospital27 enrolled1 locationNCT06388031
Recruiting
Not Applicable

Biomarkers in Immunotherapy of Melanoma

Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1 more
Institute of Oncology Ljubljana150 enrolled1 locationNCT05878977
Recruiting

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

NSCLCImmunotherapyLung Diseases, Interstitial
Universitaire Ziekenhuizen KU Leuven70 enrolled1 locationNCT04807114
Recruiting

Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer

Hunan Province Tumor Hospital15,000 enrolled1 locationNCT05059951